Multicenter phase II trial of transanal total mesorectal excision for rectal cancer: preliminary results.

Patricia SyllaDana SandsAlison RicardoAntoinette BonaccorsoAlexandros PolydoridesMariana BerhoJohn MarksJustin MaykelKarim AlaviKaren ZaghiyanMark WhitefordElisabeth MclemoreSami ChadiSherief F ShawkiScott SteeleAlessio PigazziMatthew AlbertTeresa DeBeche-AdamsErin MoshierSteven D Wexner

Published in: Surgical endoscopy (2023)

When performed at expert centers, 2-team taTME in patients with low rectal tumors is safe with low conversion rates and high stoma closure rate. Mid-term results will further evaluate oncologic and functional outcomes.

Keyphrases

rectal cancer
locally advanced
palliative care
clinical practice
prostate cancer
cross sectional
randomized controlled trial
minimally invasive
robot assisted
radical prostatectomy